First AD

Second AD

HER2CLIMB-02 Trial: Exploring Tucatinib and T-DM1 for HER2+ mBC

Video content above is prompted by the following:

 demonstrated, and what implications may these findings have on treatment practices? (

Hurvitz S et al, SABCS 2023. Abstract GS01-10

Video Series

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

My Treatment Approach: Advancing Treatment Strategies for HER2+ Metastatic Breast Cancer  

Panelists discuss recent data from the HER2CLIMB-02 trial, highlighting the findings and their implications for treatment practices in HER2-positive breast cancer, particularly for patients with brain metastases.